SCHEMBL19735675

SCHEMBL19735675

c1ccc(-c2cc(-c3ccccc3)nc(-c3cccc(C4(c5ccccc5)c5ccccc5C5(c6ccccc6)c6ccccc6-c6cccc4c65)c3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 9/20 0.43
▸ KMT2A Q03164 9/20 0.43
▸ MAPT P10636 8/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ HPGD P15428 4/20 0.43
▸ LMNA P02545 4/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ NTSR1 P30989 1/20 0.39
▸ GLA P06280 1/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.37
▸ OPRK1 P41145 1/20 0.37
▸ ADORA1 P30542 4/20 0.36
▸ TDP1 Q9NUW8 3/20 0.36
▸ ADORA2A P29274 2/20 0.36
▸ AGTR1 P30556 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ ESR1 P03372 1/20 0.35
▸ ESR2 Q92731 1/20 0.35
▸ CYP1A2 P05177 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19735637 0.97 MEN1 (0.41) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19735679 0.96 MEN1 (0.43) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19293760 0.94 MEN1 (0.47) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL26741115 0.93 MEN1 (0.50) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19735636 0.92 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19735677 0.92 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19293786 0.92 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19735608 0.92 MEN1 (0.42) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19293776 0.92 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19293768 0.92 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9960357-B2 Spiro-type compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2018-05-01 — — US disclosed
US-9960357-B2 Spiro-type compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2018-05-01 — — US disclosed
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-12-21 — — US disclosed
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-12-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, NR2E3, LEF1 MEN1 426/4885KMT2A 1141/4885MAPT 1516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback